Published in Am J Surg Pathol on December 01, 1995
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol (2008) 3.22
Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol (1999) 2.34
Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg (2007) 2.25
Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg (2005) 2.19
Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg (2013) 2.12
Pseudomyxoma peritonei. World J Gastrointest Oncol (2010) 1.76
Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis. Case Rep Oncol Med (2016) 1.44
Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol (2002) 1.42
Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix. J Am Coll Surg (2015) 1.39
Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms. J Clin Pathol (2000) 1.38
Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol (2011) 1.18
Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg (2004) 1.14
Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol (2012) 1.12
Recent concepts of ovarian carcinogenesis: type I and type II. Biomed Res Int (2014) 1.11
Primary signet ring cell carcinoma of the appendix: a rare case report and our 18-year experience. World J Gastroenterol (2008) 1.11
Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg (2001) 1.09
Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Ann Surg (2013) 1.05
Pseudomyxoma peritonei--a revisit: report of 2 cases and literature review. World J Surg Oncol (2006) 1.00
Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol (2013) 0.99
A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. Br J Cancer (2006) 0.99
Mucus containing cystic lesions "mucocele" of the appendix: the unresolved issues. Int J Surg Oncol (2015) 0.98
Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Ann Surg Oncol (2008) 0.97
Pseudomyxoma peritonei: a need to establish evidence-based standard of care--is this the right trial? Ann Surg Oncol (2009) 0.95
A rare cause of ascites: pseudomyxoma peritonei and a review of the literature. Clin Case Rep (2014) 0.95
Pseudomyxoma peritonei: unusual origin from an ovarian mature cystic teratoma. J Clin Pathol (2005) 0.92
Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review. Cancer Imaging (2013) 0.92
Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei. World J Gastroenterol (2008) 0.91
A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei. Orphanet J Rare Dis (2013) 0.90
Appendiceal mucocele and pseudomyxoma peritonei; the clinical boundaries of a subtle disease. Am J Case Rep (2014) 0.90
Intraductal papillary mucinous neoplasm (IPMN) with extra-pancreatic mucin: a case series and review of the literature. J Gastrointest Surg (2012) 0.89
Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy. Oncologist (2010) 0.88
Clinicopathological analysis of primary epithelial appendiceal neoplasms. Med Oncol (2009) 0.87
Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol (2013) 0.87
Pseudomyxoma peritonei: An uncommon tumor. Indian J Med Paediatr Oncol (2010) 0.87
CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging (2011) 0.87
Pseudomyxoma peritonei presenting as inguinal hernia. Ulster Med J (2009) 0.86
The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base. Cancer (2015) 0.85
Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival. Gastroenterol Res Pract (2012) 0.85
Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy. World J Surg Oncol (2009) 0.85
Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis (2011) 0.85
Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis. J Hum Genet (2013) 0.84
Challenges of efficacy assessments in pseudomyxoma peritonea. Oncologist (2015) 0.84
Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat Genet (2015) 0.83
Low grade peritoneal mucinous carcinomatosis associated with human papilloma virus infection: case report. Croat Med J (2008) 0.83
Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol (2014) 0.82
Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future. J Gastrointest Oncol (2016) 0.82
Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma. Int J Exp Pathol (2010) 0.82
Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers. Oncologist (2015) 0.81
Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4). World J Surg Oncol (2008) 0.81
Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects. Orphanet J Rare Dis (2014) 0.80
Pseudomyxoma peritonei. Curr Health Sci J (2009) 0.80
Intraperitoneal hyperthermic chemotherapy: experience at Baylor University Medical Center. Proc (Bayl Univ Med Cent) (2002) 0.80
Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei. Indian J Surg Oncol (2016) 0.80
Chemo-hyperthermic peritoneal perfusion (CHPP) for appendiceal pseudomyxoma peritonei. Int J Clin Oncol (2009) 0.79
Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg (2013) 0.79
Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. Curr Oncol (2015) 0.78
Pseudomyxoma peritonei of 92 Chinese patients: clinical characteristics, pathological classification and prognostic factors. World J Gastroenterol (2012) 0.78
Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters. Am J Cancer Res (2014) 0.77
Malignant abdominal rocks: where do they come from? Cancer Imaging (2013) 0.77
Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei. Ann Surg Oncol (2012) 0.77
Pseudomyxoma peritonei as an intractable disease and its preoperative assessment to help improve prognosis after surgery: A review of the literature. Intractable Rare Dis Res (2012) 0.76
Surgical treatment of peritoneal carcinomatosis: current treatment modalities. Langenbecks Arch Surg (2013) 0.76
Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Gastrointest Oncol (2013) 0.76
Malignant glomus tumor of the peritoneum: case report. Korean J Radiol (2014) 0.75
Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis. World J Surg Oncol (2014) 0.75
Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes. J Gastrointest Oncol (2016) 0.75
Giant appendix or an appendiceal mucocele? Case report of an 11-year-old child. Interv Med Appl Sci (2014) 0.75
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours. Indian J Surg Oncol (2015) 0.75
Role of Imaging in Peritoneal Surface Malignancies. Indian J Surg Oncol (2016) 0.75
Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis. World J Surg Oncol (2016) 0.75
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei. Ann Surg Oncol (2015) 0.75
A weeping umbilical hernia: bilateral ovarian mucinous cystadenoma with disseminated peritoneal adenomucinosis. BMJ Case Rep (2014) 0.75
Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel. Case Rep Oncol (2016) 0.75
Psuedomyxoma peritonei secondary to adenocarcinoma of the cecum. J Family Community Med (2010) 0.75
Interstitial pneumonitis following intrapleural chemotherapy. World J Surg Oncol (2009) 0.75
Re: JSLS. 2009;13(2):203-206 Laparoscopic mucin removal in patients with pseudomyxoma peritonei. JSLS (2010) 0.75
Low-Grade Appendiceal Mucinous Neoplasm Presenting as an Adnexal Mass. Case Rep Obstet Gynecol (2017) 0.75
Acute appendicitis, inflammatory appendiceal mass and the risk of a hidden malignant tumor: a systematic review of the literature. World J Emerg Surg (2017) 0.75
Primary signet ring cell carcinoma of the appendix: A rare case report. World J Clin Cases (2015) 0.75
Case of intraperitoneal sepsis secondary to rupture of the appendix on the background of pseudomyxoma peritonei. Ann Med Surg (Lond) (2014) 0.75
Transformation of low-grade mucinous neoplasm of the appendix with pseudomyxoma peritonei to high-grade sarcomatoid carcinoma. J Clin Med Res (2015) 0.75
Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol (2012) 0.75
Aggressive pseudomyxoma peritonei: a case report with an unusual clinical presentation. Case Rep Oncol Med (2013) 0.75
Preoperative Preparation and Patient Selection for Cytoreductive Surgery and HIPEC. Indian J Surg Oncol (2016) 0.75
Application of advanced multimodality care to pseudomyxoma peritonei patient: report of first patient treated at a tertiary center. Indian J Surg Oncol (2010) 0.75
The appropriate management of an appendiceal mucocele. BMJ Case Rep (2015) 0.75
Pseudomyxoma peritonei: disseminated peritoneal adenomucinosis variant. BMJ Case Rep (2011) 0.75
Pregnancy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei. Case Rep Surg (2014) 0.75
Progression of peritoneal adenomucinosis to the scrotum: a rare occurrence treated with cytoreductive surgery and hyperthermic chemoperfusion of the scrotum in two patients. Colomb Med (Cali) (2014) 0.75
Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment. Cancer Med (2016) 0.75
Pseudomyxoma peritonei extending to the lower extremity: a case report. World J Surg Oncol (2015) 0.75
Limited, local, extracolonic spread of mucinous appendiceal adenocarcinoma after perforation with formation of a malignant appendix-to-sigmoid fistula: Case report and literature review. World J Gastroenterol (2016) 0.75
Not all "mucinous carcinomas" are equal: time to redefine and reinvestigate the biologic significance of mucin types and patterns in the GI tract. Virchows Arch (2005) 0.75
Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade. World J Gastrointest Oncol (2017) 0.75
FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei. Eur J Nucl Med Mol Imaging (2016) 0.75
The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre. J Cancer Res Clin Oncol (2014) 0.75
Appendiceal Mucinous Neoplasms: Diagnosis and Management. Oncologist (2017) 0.75
[Mucinous neoplasms of the vermiform appendix, Pseudomyxoma peritonei, and the new WHO classification]. Pathologe (2012) 0.75
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol (1991) 4.62
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol (2004) 4.15
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol (1996) 3.63
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (1995) 3.59
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J Cell Biol (1989) 3.55
The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer (1985) 3.50
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA (1999) 3.37
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res (1996) 3.00
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (1999) 2.98
Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol (2000) 2.96
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg (1987) 2.54
Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol (1998) 2.50
Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst (1987) 2.45
Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg (2004) 2.33
Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol (1999) 2.25
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24
Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev (1984) 2.15
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med (1972) 2.11
Appendiceal mucocele. Contraindication to laparoscopic appendectomy. Surg Endosc (1998) 2.10
Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg (2000) 2.08
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol (1999) 2.02
Liposarcoma of the extremities: MR and CT findings in the histologic subtypes. Radiology (1993) 2.01
Pseudomyxoma peritonei syndrome. Adv Surg (1996) 1.99
The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol (2001) 1.98
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol (2006) 1.96
Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol (1998) 1.93
Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery (1982) 1.86
Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg (1988) 1.81
Preoperative laparoscopy in diagnosis of acute abdominal pain. Lancet (1975) 1.78
Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg (2001) 1.77
PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res (1998) 1.77
Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis (1993) 1.72
Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst (1997) 1.72
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. Int J Gynecol Cancer (2007) 1.70
Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg (1989) 1.70
Characteristics of cell lines established from human colorectal carcinoma. Cancer Res (1987) 1.69
p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol (1997) 1.67
Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg (1985) 1.65
Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol (1996) 1.65
Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography. Radiology (1990) 1.65
Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol (1995) 1.64
Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum Gene Ther (1999) 1.63
The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer (2000) 1.61
Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol (1997) 1.61
A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol (1997) 1.61
Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer (1985) 1.61
Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. Am J Surg Pathol (1998) 1.59
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol (2010) 1.59
Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery (1993) 1.58
Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol (1998) 1.58
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57
Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol (1997) 1.55
A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol (2000) 1.54
Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary? Ann Surg Oncol (2001) 1.53
Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol (1995) 1.53
A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol (2000) 1.51
Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol (2000) 1.50
p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol (1995) 1.50
Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer (1976) 1.49
Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis (1993) 1.48
The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix. Hum Pathol (1986) 1.45
Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol (1999) 1.45
Repeat hepatic resections for colorectal metastases. Surgery (1990) 1.45
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res (1981) 1.45
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol (1997) 1.44
Serial carcinoembryonic antigen assays. Use in detection of cancer recurrence. JAMA (1974) 1.44
Trophoblastic pseudotumor of the uterus: an exaggerated form of "syncytial endometritis" simulating a malignant tumor. Cancer (1976) 1.43
Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol (1997) 1.42
Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gene Ther (2000) 1.41
Prosthetic mesh repair of large hernias at the site of colonic stomas. Surg Gynecol Obstet (1980) 1.40
Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer (1998) 1.38
Peritoneal approach to prosthetic mesh repair of paraostomy hernias. Ann Surg (1985) 1.36
A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery (1987) 1.35
Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg (1994) 1.35
Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol (1992) 1.34
Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am (1989) 1.33
Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery (1985) 1.33
Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer (1993) 1.29
Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol (1972) 1.29
A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci U S A (2001) 1.29
Giant cell tumor of the tendon sheath: MR findings in nine cases. AJR Am J Roentgenol (1994) 1.29
Patterns of serial CEA assays and their clinical use in management of colorectal cancer. J Surg Oncol (1976) 1.27
Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas. Am J Obstet Gynecol (1981) 1.27
A prospective study of hepatic imaging in the detection of metastatic disease. Ann Surg (1982) 1.26
Liposarcoma occurring in children. An analysis of 17 cases and review of the literature. Cancer (1983) 1.24